4-(benzyloxycarbonylamino)benzamide | 500545-36-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(benzyloxycarbonylamino)benzamide
• 英文别名: Benzyl 4-(aminocarbonyl)phenylcarbamate；benzyl N-(4-carbamoylphenyl)carbamate
• CAS: 500545-36-8
• 化学式: C₁₅H₁₄N₂O₃
• mdl: MFCD05874736
• 分子量: 270.288
• InChiKey: PEIQAQYSTLVEKP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.066
• 拓扑面积：
  81.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(benzyloxycarbonylamino)benzamide 在 甲醇 、 sodium tetrahydroborate 、 nickel(II) chloride hexahydrate 作用下， 反应 0.25h， 以85%的产率得到对氨基苯甲酰胺
  参考文献：
  名称：

  Development of a novel protocol for chemoselective deprotection of N/O-benzyloxycarbonyl (Cbz) at ambient temperature

  摘要：

  A novel protocol for the deprotection of N-benzyloxycarbonyl and O-benzyloxycarbonyl groups by nickel boride generated in situ from NaBH4 and NiCl(2)6H(2)O in methanol at room temperature has been developed to give the corresponding amines and phenols. This protocol is chemoselective as groups like chloro, bromo, amide, ester, pyridine, and tert-butyloxycarbonyl moiety are unaffected under these conditions. The deprotection has also been validated in gram scale reactions, to establish the wider appropriateness of this protocol.

  DOI：

  10.1007/s00706-018-2276-x
• 作为产物：
  描述：

  对氨基苯甲酰胺 、 氯甲酸苄酯 在 sodium carbonate 作用下， 以 四氢呋喃 为溶剂， 以97%的产率得到4-(benzyloxycarbonylamino)benzamide
  参考文献：
  名称：

  Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing heterobiaryl carboxylic acids

  摘要：

  The design, synthesis, and SAR of a novel series of heterobiaryl phenethanolamine beta(3) adrenergic receptor agonists are described. The furan analogue 49 was shown to elicit a significant dose-dependent lowering of plasma glucose in a rodent model of type 2 diabetes. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.05.069

文献信息

• [EN] CYCLOPROPYLAMINE DERIVATIVES USEFUL AS INHIBITORS OF HISTONE DEMETHYLASES KDM1A<br/>[FR] DÉRIVÉS DE CYCLOPROPYLAMINE UTILES EN TANT QU'INHIBITEURS DE HISTONE DÉMÉTHYLASES KDM1A
  申请人：ISTITUTO EUROP DI ONCOLOGIA S R L

  公开号：WO2014086790A1

  公开（公告）日：2014-06-12

  (I) The present invention relates to cyclopropyl derivatives of general formula (I), wherein A, R1, and R2 are as defined in the specification. The present application also relates to pharmaceutical compositions containing such compounds and to their use in therapy.

  本发明涉及一般式(I)的环丙基衍生物，其中A、R1和R2如规范中定义。本申请还涉及含有这类化合物的药物组合物以及它们在治疗中的应用。
• Rhodium Carbene Routes to Oxazoles and Thiazoles. Catalyst Effects in the Synthesis of Oxazole and Thiazole Carboxylates, Phosphonates, and Sulfones
  作者：Baolu Shi、Alexander J. Blake、William Lewis、Ian B. Campbell、Brian D. Judkins、Christopher J. Moody

  DOI：10.1021/jo902256r

  日期：2010.1.1

  Dirhodium tetraacetate catalyzed reaction of α-diazo-β-keto-carboxylates and -phosphonates with arenecarboxamides gives 2-aryloxazole-4-carboxylates and 4-phosphonates by carbene N−H insertion and cyclodehydration. In stark contrast, dirhodium tetrakis(heptafluorobutyramide) catalysis results in a dramatic change of regioselectivity to give oxazole-5-carboxylates and 5-phosphonates. α-Diazo-β-ketosulfones

  四乙酸二丁酯催化α-重氮-β-酮基羧酸酯和-膦酸酯与芳烃酰胺的反应，通过卡宾NH插入和环脱水作用，制得2-芳基恶唑-4-羧酸酯和4-膦酸酯。与之形成鲜明对比的是，四（七氟丁酰胺）四氢吡啶鎓催化作用会导致区域选择性的显着变化，从而产生5-羧酸恶唑酯和5-膦酸酯。α-重氮-β-酮砜的行为相似，在四（七氟丁酰胺）四氢吡啶鎓与羧酰胺的催化反应下生成5-磺酰基恶唑。硫代羧酰胺的类似反应得到相应的噻唑-5-羧酸盐，-膦酸酯和-砜。
• CYCLOPROPYLAMINE DERIVATIVES USEFUL AS INHIBITORS OF HISTONE DEMETHYLASES KDM1A
  申请人：INSTITUTO EUROPEO DI ONCOLOGIA S.R.L.

  公开号：US20150315126A1

  公开（公告）日：2015-11-05

  The present invention relates to cyclopropyl derivatives of general formula (I), wherein A, R 1 , and R 2 are as defined in the specification. The present application also relates to pharmaceutical compositions containing such compounds and to their use in therapy.

  本发明涉及一般式(I)的环丙基衍生物，其中A、R1和R2如规范中所定义。本申请还涉及含有这种化合物的药物组合物以及它们在治疗中的使用。
• US9944589B2
  申请人：——

  公开号：US9944589B2

  公开（公告）日：2018-04-17
• Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing heterobiaryl carboxylic acids
  作者：Barry G. Shearer、Esther Y. Chao、David E. Uehling、David N. Deaton、Conrad Cowan、Bryan W. Sherman、Tula Milliken、Walter Faison、Kathleen Brown、Kimberly K. Adkison、Frank Lee

  DOI：10.1016/j.bmcl.2007.05.069

  日期：2007.8

  The design, synthesis, and SAR of a novel series of heterobiaryl phenethanolamine beta(3) adrenergic receptor agonists are described. The furan analogue 49 was shown to elicit a significant dose-dependent lowering of plasma glucose in a rodent model of type 2 diabetes. (c) 2007 Elsevier Ltd. All rights reserved.